CRISPR THERAPEUTICS AG Payments to Acquire Debt Securities, Available-for-sale
CRISPR THERAPEUTICS AG (CRSP) reported Payments to Acquire Debt Securities, Available-for-sale of $500.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2020-02-12.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2020-02-12
- CRISPR THERAPEUTICS AG payments to acquire debt securities, available-for-sale for the quarter ending 2017-12-31 was $0.00.
- CRISPR THERAPEUTICS AG payments to acquire debt securities, available-for-sale for fiscal 2017 was $500.00K.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 9 month | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | $500.00K 10-K · filed 2020-02-12 | |
| 2017-09-30 | $500.00K 10-Q · filed 2018-11-07 | ||
| 2016-09-30 | $100.00K 10-Q · filed 2017-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |